Taiwan Bio-Manufacturing Corporation (TBMC)
- CMO, CRO
- Other R&D services
Taiwan Bio-Manufacturing Corporation (TBMC), founded in May 2023, specializes in CRDMO for advanced therapeutics, including mRNA, viral vectors, cell therapies, and biologics. Committed to high-quality biomanufacturing, TBMC offers end-to-end mRNA production, covering plasmid DNA, sequence optimization, IVT, and LNP formulation. Our viral vector services support research and preclinical development. The cell therapy platform enables cost effective regenerative and immune therapy production, such as MSC stem cell and CarT cell. For biologics, our proprietary CHO-C platform enables rapid protein production and process development, enhanced by Raman spectroscopy for real-time monitoring of 30+ key metabolic parameters. Backed by trust, speed, flexibility, innovation, and expertise, TBMC helps biotech companies transition seamlessly to manufacturing.



